Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diacetylrhein, an anthraquinone antiarthritic agent, suppresses dextran sodium sulfate-induced inflammation in rats: A possible mechanism for a protective effect against ulcerative colitis
Mona H. Zohny, Mohammed Alrouji, Sharif Alhajlah, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113651-113651
Open Access | Times Cited: 15

Showing 15 citing articles:

Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
Rasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel‐Reheim, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review
Bo Chen, Xinqian Dong, Jinlong Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Anti-inflammatory, anti-colitis, and antioxidant effects of columbianadin against DSS-induced ulcerative colitis in rats via alteration of HO-1/Nrf2 and TLR4-NF-κB signaling pathway
Yanping Zhang, Ping Cao, Dongyuan Qin, et al.
Inflammopharmacology (2025)
Closed Access
Ferulic acid lipid nano capsules versus its native form in alleviating diabetic nephropathy induced in rats through TGF-β1/Hippo pathway crosstalk modulation
Mona H. Zohny, Yousra M. El‐Far, Mohamed Fawzi Kabil, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Regulation of pyroptosis by natural products in ulcerative colitis: mechanisms and therapeutic potential
Xiaobei Lu, Yapeng Sun, Zhaoyi Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Targeting programmed cell death in inflammatory bowel disease through natural products: New insights from molecular mechanisms to targeted therapies
Mengjie Wang, Zhiyuan Wang, Zhichao Li, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 3
Moxibustion mitigates mitochondrial dysfunction and NLRP3 inflammatory activation in cyclophosphamide-induced premature ovarian insufficiency rats
Yaoli Yin, Hongxiao Li, Yantong Qin, et al.
Life Sciences (2022) Vol. 314, pp. 121283-121283
Open Access | Times Cited: 13
Renoprotective effect of diacetylrhein on diclofenac-induced acute kidney injury in rats via modulating Nrf2/NF-κB/NLRP3/GSDMD signaling pathways
Abduallah Nasser Mansoure, Mahmoud Elshal, Manar G. Helal
Food and Chemical Toxicology (2024) Vol. 187, pp. 114637-114637
Closed Access | Times Cited: 2
DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering
Oliver Sandys, Pieter Stokkers, Anje A. te Velde
Digestive Diseases and Sciences (2024)
Open Access | Times Cited: 2
Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles
Elsayed A. Elmorsy, Mahmoud E. Youssef, Mohamed R Abdel-Hamed, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Rutin mitigates acetic acid-induced ulcerative colitis: novel coloprotective mechanism
Iman O. Sherif, Nora Hamad Al‐Shaalan, Walaa Awadin
Toxicology Research (2024) Vol. 13, Iss. 4
Closed Access | Times Cited: 1
An Integrative analysis of single-cell RNA-seq, transcriptome and Mendelian randomization for the Identification and validation of NAD+ Metabolism-Related biomarkers in ulcerative colitis
Longxiang Zhang, Jian Li, Qiqi Zhang, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113765-113765
Open Access | Times Cited: 1
Tracking the therapeutic efficacy of a ketone mono ester and β-hydroxybutyrate for ulcerative colitis in rats: New perspectives
Osama A. Mohammed, Sameh Saber, Mustafa Ahmed Abdel‐Reheim, et al.
Toxicology and Applied Pharmacology (2024) Vol. 486, pp. 116943-116943
Closed Access | Times Cited: 1
Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis
You Huang, Qiuhong Wu, Sha Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Charge balanced aggregation: A universal approach to aqueous organic nanocrystals
Wenwen Zhao, Qiu Li, Peng He, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 552-573
Closed Access | Times Cited: 1
Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease
Mohammad Aadil Bhat, I. N. Usman, Suneela Dhaneshwar
Current Reviews in Clinical and Experimental Pharmacology (2023) Vol. 19, Iss. 3, pp. 234-249
Closed Access | Times Cited: 3
Bioinformatics analysis reveals potential crosstalk genes and molecular mechanisms between ulcerative colitis and psoriasis
Qinghua Luo, Ming-Wei An, Yunxiang Wu, et al.
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access
Page 1

Scroll to top